Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tomas David Sipos Insider Profile
4 Followers
Tomas David Sipos, Director at Predictmedix, holds 250.00K shares in Predictmedix (Ticker: PMEDF). Most recently, Tomas David Sipos ― shares of Predictmedix on ― for an estimated value of ―.
Tomas David Sipos has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Tomas David Sipos's holdings
Insider Roles
Director
Roles that Tomas David Sipos holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Tomas David Sipos
Tomas David Sipos's Trading History
List of latest transactions for each holding click on a transaction to see Tomas David Sipos's performance on stock
You May Also Like
Tomas David Sipos insider profile FAQ
What is the percentage of profitable transactions made by Tomas David Sipos?
The percentage of profitable transactions made by Tomas David Sipos is ―.
What is the average return per transaction made by Tomas David Sipos?
The average return per transaction made by Tomas David Sipos is ―.
What stocks does Tomas David Sipos hold?
Tomas David Sipos holds: PMEDF stocks.
What was Tomas David Sipos’s latest transaction?
Tomas David Sipos latest transaction was an Uninformative Buy of ―.
What was Tomas David Sipos's most profitable transaction?
Tomas David Sipos’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Tomas David Sipos's role in Predictmedix?
Tomas David Sipos's role in Predictmedix is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.